-
Cuban's pharmacy isn't always the cheapest, but cost isn't the focus, CEO says
As Mark Cuban works to "just f— up the pharmaceutical industry so bad that they bleed," his online pharmacy, Mark Cuban Cost Plus Drug Co., does not always offer the lowest prices. Individual generics aren't the main goal, though, Kaiser Health News reported Feb. 17. -
Pharmacy group praises 2 bills aimed at 'sneaky' PBMs
The National Community Pharmacists Association hailed the Senate Judiciary Committee for its decision to greenlight two bills targeting pharmacy benefit managers. -
Antibiotics tied to rare, serious drug-related skin reactions: Study
Antibiotic use has been linked to two rare but painful and sometimes deadly skin reactions: Stevens-Johnson syndrome and toxic epidermal necrolysis, a new study reports. -
Harvard, Brigham and Women's identify potential targets for new antibiotics
Research from scientists at Harvard Medical School and Brigham and Women's Hospital, both in Boston, have uncovered two families of proteins that may pave the way for the development of new antibiotics in the future. -
Thousands can't access a vital cancer drug treatment
The bladder cancer drug Bacillus Calmette-Guerin is in shortage, forcing thousands of patients to receive rationed treatments instead of a full regimen, CNN reported Feb. 15. -
Report: Heartburn drug's cancer risks were kept quiet for decades
Ranitidine, a heartburn medication sold under the brand name Zantac, was removed from shelves in 2020 after the FDA found a contaminant in it known to cause cancer. -
Moderna promises $0 cost for its COVID-19 vaccine post PHE
As the federal public health emergency for COVID-19 is set to end May 11, Moderna whistled a new tune Feb. 15, saying both insured and uninsured Americans will not pay a price for its vaccine. -
10 systems seeking pharmacy leaders
The following 10 hospitals, health systems and hospital operators have posted job listings seeking pharmacy leaders in the last week. -
57% of physicians say social media changed their views on medications
Nearly 6 in 10 physicians said in a survey that social media either frequently or occasionally changed their perception of a medication or treatment. -
COVID-19 antiviral may lead to slow heart rate, study finds
Remdesivir, an FDA-approved COVID-19 treatment, may carry a risk of bradycardic events — or a slowed heart rate — among hospitalized patients who had bradycardia, according to a study published Feb. 14 in JAMA. -
Kaiser shifts patients' prescriptions to its own pharmacies, mail-order sites
Kaiser Permanente moved people's prescriptions out of network pharmacies and into its own locations and mail-order sites — but patients expressed worries about the change, the Moscow-Pullman Daily News reported Feb. 11. -
HHS unveils 3 new drug price models
HHS is taking aim at high prescription drug costs through three new programs announced Feb. 14. -
Pharmacists who prescribe found to be effective, safe in long-term care
Pharmacists allowed to prescribe medications to patients in long-term care facilities helped reduce drug burdens, according to a U.K. study published Feb. 14 in The BMJ. -
New York hospital swaps out 20-year-old script-filling robot
NYC Health + Hospitals' Elmhurst location dismantled its 20-year-old prescription-filling robot and replaced it with another that can fill 120 prescriptions each hour and carry 140 products, the site's pharmacy director, Peter Barber, PharmD, told Becker's. -
4 notes for clinicians on the newly revised immunization schedules
Immunization schedules have been revised for U.S. adults and children as of Feb. 10 for 2023 with new guidelines for COVID-19; measles, mumps and rubella; hepatitis B; and pneumococcal vaccination. -
1 in 10 recently approved drugs avoided their trial's goals: study
The FDA doesn't always approve drugs and medical devices that pass their trial goals, according to a study led by researchers from New Haven, Conn.-based Yale School of Medicine and Boston's Brigham and Women's Hospital. -
ASHP asks Biden for expanded pharmacists roles amid opioid epidemic
The American Society of Health-System Pharmacists' CEO sent President Joe Biden a letter Feb. 13 asking him to allow pharmacists to "finish the job" with lessening the nation's opioid use disorder epidemic. -
Baptist to break ground for 9-hospital central pharmacy in March
Louisville, Ky.-based Baptist Health partnered with pharmacy automation company Parata Systems to construct a mail-order and specialty pharmacy in Northern Kentucky "that will serve the entire nine-hospital system," according to a news release shared with Becker's. -
A look at 5 pharma bills backed by the ASHP
On Feb. 9, the Senate Judiciary Committee passed five bills supported by the American Society of Health-System Pharmacists that target pharmacy benefit managers and patent thickets. -
22 pharmacies to close in California after Walgreens deal
Pharmaca Integrative Pharmacies will close 22 storefronts in California after it was acquired by Walgreens, The U.S. Sun reported Feb. 11.
Page 35 of 50